Dawn A Fishbein MD
HIV/AIDS Medicine
Medical Director, DC Partnership for HIV/AIDS Progress Subspecialty Clinics
Join to view full profile
110 Irving St NwSte 2a56Washington, DC 20010
Phone+1 202-877-7164
Fax+1 202-877-0341
Dr. Fishbein is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 2001 - 2004
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1998 - 2001
Albert Einstein College of MedicineClass of 1998
Certifications & Licensure
DC State Medical License 2009 - 2027
NY State Medical License 1999 - 2020
MD State Medical License 2010 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Centricity EMR, GE Healthcare, 2013-2017
- CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2013-2017
- CMS Meaningful Use Stage 2 Certification MEDSEEK Empower, SymphonyCare, LLC, 2013-2017
Publications & Presentations
PubMed
- 2 citationsLong-term Follow-up of Hepatitis C Patients Who Achieved Sustained Virologic Response in the Pragmatic PRIORITIZE Study.Anna S Lok, Juhi Moon, Kenneth E Sherman, Mandana Khalili, Dawn Fishbein
Clinical Gastroenterology and Hepatology. 2023-02-01 - 8 citationsHCV universal EHR prompt successfully increases screening, highlights potential disparities.Benjamin Hack, Kavya Sanghavi, Sravya Gundapaneni, Stephen Fernandez, Justin Hughes
Plos One. 2023-01-01 - 2 citationsOral Prescription Opioids as a High-Risk Indicator for Hepatitis C Infection: Another Step Toward HCV Elimination.Benjamin Hack, Utsav Timalsina, Eshetu Tefera, Brittany Wilkerson, Emily Paku
Journal of Primary Care & Community Health. 2021-09-01
Grant Support
- Protective Immunity To HBV In HIV+ Patients With Isolated Hepatitis BNational Center For Research Resources2009
- Protective Immunity To HBV In HIV+ Patients With Isolated HBV Core AntibodyNational Center For Research Resources2008
- Pre-Chemotherapeutic Care Of HCV Infected Drug UsersNational Institute On Drug Abuse2004–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
